Figure 1.

Lovastatin‐reduced cell viability in breast cancer cells. MCF‐7 (A), T47D (B), MDA‐MB‐231 (C) or MDA‐MB‐468 (D) breast cancer cells were treated with vehicle or lovastatin at indicated concentrations for 24 or 48 h. Cell viability was determined by an MTT assay. Each column represents the mean ± SEM of six independent experiments performed in duplicate (Statistically significant differences were determined using the Kruskal‐Wallis test. *P < .05, compared with the control group). Technical replicates were used to ensure the reliability of singe values for each experiment